Synergistic effect of scavenger receptor A and low-density lipoprotein receptor on macrophage foam cell formation under inflammatory stress

  • Authors:
    • Tianyi Su
    • Lei Zhao
    • Xiongzhong Ruan
    • Guoqing Zuo
    • Jianping Gong
  • View Affiliations

  • Published online on: November 8, 2012     https://doi.org/10.3892/mmr.2012.1170
  • Pages: 37-42
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

To provide experimental evidence for the effect of inflammation on cholesterol accumulation in macrophages, we investigated the expression of low-density lipoprotein receptor (LDL-R) and scavenger receptor A (SR-A) genes and proteins in the lipopolysaccharide (LPS)-stimulated macrophage-like RAW264.7 cell line. RAW264.7 cells were incubated in serum-free medium in the absence or presence of LDL alone, LDL + LPS and LPS alone. Intracellular cholesterol content, tumor necrosis factor α levels in the supernatants, mRNA and protein expression of LDL-R and SR-A in the treated cells were assessed by Oil Red O staining cholesterol enzymatic assay, enzyme-linked immunosorbent assay, semi-quantitative polymerase chain reaction and western blot analysis, respectively. Our results demonstrated that LPS was able to upregulate SR-A mRNA and protein expression, override LDL-R suppression induced by a high dose of LDL and increase LDL uptake by enhancing receptor expression, leading to foam cell formation in RAW264.7 cells. These findings suggest that the synergy of the upregulation of SR-A and dysregulation of LDL-R under inflammatory stress may contribute to macrophage-derived foam cell formation.

Introduction

Atherosclerosis is characterized by the accumulation of lipids, mainly cholesterol and cholesterol esters, and the infiltration of inflammatory cells, particularly macrophages. Recent experimental and clinical evidence suggest that inflammation plays a significant role in lipid-mediated cell injury (e.g., atherosclerosis) (14). Retention of lipoproteins in the artery wall is one of the primary events in atherosclerosis (5,6). In the vessel wall, low-density lipoprotein (LDL) is trapped by matrix proteoglycans and becomes susceptible to various modifications that trigger local inflammatory responses leading to recruitment of macrophages in the arterial wall (7). Uptake of modified LDL by macrophages leads to foam cell formation, which is characteristic of early atherosclerotic lesions (8).

Cardiovascular risk is increased in chronic inflammatory states, up to 33-fold in patients with renal failure and 50-fold in patients with immune dysregulation (912). These diseases are often associated with inflammatory stress with elevated inflammatory markers and inflammatory cytokines. However, most mechanisms linking atherosclerosis to inflammatory stress remain to be identified. Inflammation and infection may affect the plasma levels of cholesterol and lipoproteins by modulating the synthesis and secretion of apolipoproteins, the activity of lipolytic enzyme or the expression of lipoprotein receptors. Two of the major determinants of plasma cholesterol levels are the result of the activity of the scavenger receptor A (SR-A), mediating uptake of modified LDL and LDL receptor (LDL-R), and mediating uptake of native LDL in macrophages. SR-A is expressed in human atherosclerotic lesions (13,14), and they have been shown to contribute to the uptake of modified LDL (15). Since this uptake of cholesterol through the macrophage scavenger receptors is poorly regulated, excess cholesterol accumulation leads to macrophage-derived foam cell formation. Macrophages play a very important role in the pathogenesis of atherosclerosis and are one of the major cell types involved in foam cell formation (16). However, the role of LDL-R and SR-A receptor in macrophages under inflammation remains unclear. The present experiment set out to investigate the effects of LPS on cholesterol accumulation in macrophages, and the expression of LDL-R and SR-A genes and proteins in the lipopolysaccharide (LPS)-stimulated macrophage-like RAW264.7 cell line in the presence of a high dose of native LDL.

Materials and methods

Cell culture

The macrophage-like RAW264.7 cell line was cultured in growth medium containing RPMI-1640 medium, 10% newborn bovine serum, 2 mmol/l glutamine, 100 U/ml penicillin and 100 μg/ml streptomycin. All experiments were carried out in serum-free RPMI-1640 medium containing 0.2% BSA, 2 mmol/l glutamine, 100 U/ml penicillin and 100 μg/ml streptomycin. All reagents for cell culture and LPS were obtained from Sigma. LDL was isolated from healthy human plasma by sequential ultra-centrifugation.

Enzyme-linked immunosorbent assay (ELISA) for tumor necrosis factor α (TNF-α)

Cultures of RAW264.7 cells were washed twice with PBS at 37°C and then overlaid with 1 ml of fresh, serum-free RPMI-1640 medium. After an incubation of 24 h, an additional 1 ml of medium with or without 100 ng/ml LPS was added. Cells were incubated for the desired time periods. The concentrations of TNF-α in cell culture medium were determined by an ELISA assay kit (eBioscience, UK) according to the manufacturer’s instructions.

Measurement of intracellular cholesterol

The method was based on the cholesterol enzymatic assay described by Gallo et al and Gamble et al(17,18). RAW264.7 cells in 6-well plates were cultured in serum-free medium without (control) or with 100 μg/ml LDL in the absence or presence of 100 ng/ml LPS for 24 h. Cells were then washed twice in PBS, intracellular lipids were extracted in isopropanol and dried under vacuum, and total cholesterol (TC), free cholesterol (FC) and cholesterol ester (CE) content were measured by enzymatic assay (CE = TC - FC) and normalized by total cell proteins determined by the modified Lowry assay.

Oil Red O stain

RAW264.7 cells were incubated in serum-free medium for 24 h. Then, these cells were differentially treated. After 24 h, cells were fixed using 5% formalin for 30 min at room temperature, soaked in Oil Red O staining solution for 30 min at room temperature and washed three times, followed by hematoxylin stain to visualize the nucleus.

Total RNA isolation and semi-quantitative RT-PCR

Total RNA was isolated from cultured cells using TRIzol reagent (Promega, USA). Total RNA (500 ng) was used as a template for RT using an RT kit from Toyoba. The RT reaction was set up in a 20-μl mixture containing 50 mmol/l KCl, 10 mmol/l Tris-HCl, 5 mmol/l MgCl2, 1 mmol/l of each deoxynucleoside triphosphate, 2.5 μmol/l random hexamers, 20 units RNAase inhibitor and 50 units Moloney-murine leukemia virus RT. Incubations were performed in a DNA Thermal Cycler (Eppendorf, USA) for 10 min at room temperature, followed by 30 min at 42°C and 5 min at 99°C. Semi-quantitative PCR was performed in a DNA Thermal Cycler (Eppendorf) using PCR Master mix (DongSheng Biotec Co., China). Thermal cycler conditions contained holds for 10 min at 95°C, followed by 30 cycles of 30 sec at 95°C, 30 sec at 51°C and 45 sec at 72°C. The PCR products were separated by electrophoresis and the relative amount of mRNA was calculated using the Genegenus system and GeneTools software version 3.05 (Synoptics, UK). GAPDH served as the reference housekeeping gene. The following oligonucleotide primers were used: SR-A upper 5′-TCAATGACAGCATCCCTTCC-3′, lower 5′-ATGTCCTCCTGTTGCTTTGC-3′; LDL-R upper 5′-TTGCAGTAGAAGACTCAGGC-3, lower 5′-ATGATT TGCAGCGGAAGTGG-3′; GAPDH upper 5′-ATTCAACGG CACAGTCAA-3′, lower 3′-TGAGGGTGAGAAGGTGGAA-5′.

Western blot analysis

Cells from a 150-ml culture bottle were pooled and allowed to swell at 4°C in 300 μl of lysis buffer (10 mmol/l HEPES, pH 7.9, 10 mmol/l KCL, 1.5 mmol/l MgCl2, 0.5 mmol/l dithiothreitol, 0.4 Nonidet P-40, 0.5 μmol/l phenylmethylsulfonyl fluoride and 1 μg/ml of antipain, leupeptin, bestatin and chymostatin) and then passed through a 23-gauge needle 20 times before centrifugation at 14,000 × g at 4°C for 15 min. The supernatant from this spin was used as the whole cell extract. Identical amounts of total protein from the whole cell extract were denatured and then subjected to electrophoresis on a 5% stacking and 8% separating SDS polyacrylamide gel in a Bio-Rad Mini Protein apparatus. Electrophoretic transfer to nitrocellulose was accomplished at 60 V, 200 mA for 2 h in 25 mmol/l Tris, pH 8.3, 192 mmol/l glycine, 0.1% SDS and 20% methanol. The membrane was then blocked with 5% skimmed milk for 1 h at room temperature, followed by two 5-min washes in PBST (phosphate-buffered saline/1% Tween). The membrane was incubated with the first antibody (goat-anti SR-A, or rabbit-anti LDL-R, rabbit-anti SREBP-2; Santa Cruz, USA) for 2 h at 37°C in antibody dilution buffer (1% BSA in PBST). The horseradish peroxidase-labeled secondary antibody (rabbit anti-goat, goat-anti rabbit; Santa Cruz) was diluted in antibody dilution buffer and then added to the membrane for 1 h at 37°C, followed by three 5-min washes in PBST. Finally, detection procedures were performed using ECL Advance Western Blotting Detection kit, in a Genegnome system (Synoptics). Band intensity volumes were measured by Quantity One software (Bio-Rad, UK).

Immunocytochemical staining

RAW264.7 cells were fixed using 5% formalin for 30 min at room temperature, and then washed three times, followed by immunocytochemical staining according to the kit (Boshide Bio-Project Co., Wuhan, China) instructions. The first antibody was rabbit anti-rabbit LDL-R antibody. Phosphate-buffered saline (PBS) substituted for the first antibody was used as the negative control. Cells with brown granules appearing in the nuclei were considered to be positively stained and indicated activation of LDL-R.

Statistical analysis

In the experiments, data are expressed as the means ± standard deviation (SD). Comparisons between two groups were performed by t-test. All analyses were carried out using the SPSS software (version 13.0; SPSS Inc., Chicago, IL, USA). P-values <0.05 were considered to indicate statistical significance.

Results

Expression levels of TNF-α in ELISA

We examined LPS-dependent TNF-α secretion in RAW264.7 cells to determine whether LPS induces TNF-α secretion in a time-dependent manner and whether LPS causes inflammatory stress. LPS-treated RAW264.7 cells secreted TNF-α, with levels beginning to increase at 4 h of incubation and reaching a maximum at 16 h and lasting until 48 h.

Intracellular cholesterol accumulation in the cholesterol enzymatic assay

We examined the effect of LPS (100 ng/ml) on the intracellular cholesterol content in RAW264.7 cells. Inflammation resulted in a TC and CE accumulation and foam cell formation in RAW264.7 cells, as evidence by the intracellular total cholesterol assay (Fig. 1A) and cholesterol ester assay (Fig. 1B).

Intracellular cholesterol accumulation as assessed by Oil Red O staining

Staining of RAW264.7 cells with Oil Red O after incubation with 100 μg/ml LDL or 100 ng/ml LPS alone showed a slight increase in lipid droplets over that of the control group (Fig. 2A-C). However, a significant increase in cholesterol accumulation was observed in RAW264.7 cells in the presence of 100 μg/ml LDL and 100 ng/ml LPS together (Fig. 2D). These data were consistent with the cholesterol enzymatic assay data.

Expression levels of LDL-R and SR-A mRNA in RT-PCR

To assess how LPS induces an increase in intracellular cholesterol content, the mRNA and protein levels of LDL-R and SR-A in RAW264.7 cells were evaluated. RAW264.7 cells were stimulated with 100 μg/ml LDL, 100 ng/ml LPS, or with 100 μg/ml LDL and 100 ng/ml LPS, respectively, for up to 24 h. mRNA was measured by semi-quantitative RT-PCR. Either LDL loading or LPS increased SR-A mRNA expression in RAW264.7 cells (Fig. 3A). LDL loading inhibited LDL-R mRNA expression and LPS disrupted this physiological feedback causing an increase in LDL-R mRNA levels in RAW264.7 cells (Fig. 3B).

Western blot analysis of the expression levels of LDL-R and SR-A protein

Western blotting demonstrated that LDL loading or LPS increased SR-A protein expression in RAW264.7 cells (P<0.05) (Fig. 4A). LDL loading inhibited LDL-R protein levels (vs. control, P<0.05) and LPS increased LDL-R levels in RAW264.7 cells (vs. LDL loading group, P<0.05) (Fig. 4B). These data were consistent with mRNA data.

Immunocytochemical analysis of LDL-R protein expression

Immunocytochemical staining showed that LDL inhibited LDL-R protein expression and LPS (100 ng/ml) overrode the suppression of the LDL-R protein expression induced by LDL loading (Fig. 5).

Discussion

As foam cell formation has long been deemed critical to lesion development, the scavenger receptors involved in lipid uptake have been causally implicated in the pathogenesis of atherosclerosis. Several studies have shown that macrophages are deemed to cause foam cells, have multiple functions, including secretion and production of growth factors, cytokines, clearance of particles in blood, and also play a key role in atherosclerosis by expression of several different cell surface receptors that can be modulated by inflammation, for cholesterol uptake and foam cell formation (16,19). SR-A is an important cell surface receptor for binding modified-LDL and plays a central role in atherosclerosis. LDL-R is the primary receptor for binding and internalization of plasma-derived LDL cholesterol and regulates plasma LDL concentrations. With respect to macrophages, several studies, although not all, have shown the effect of SR-A or LDL-R alone on foam cell formation under inflammation, however, reports on the synergic effect of LDL-R and SR-A on macrophage foam cell formation are limited. In the present study, we mainly focus on receptor-mediated macrophage-derived foam cell formation under LPS-induced inflammatory stress.

SR-A, as a classical atherogenic receptor (2022), has been studied for decades. Scavenger receptor was coined to describe the activity of macrophages which mediate the uptake of modified forms of LDL. As a central feature of the pathology of atherosclerosis, macrophage-derived foam cells are closely resembled by the resultant lipid laden macrophages (23). The class A scavenger receptor was shown to be a trimeric Type II membrane protein with a broad range of polyanionic ligands, including components of Gram-positive bacterial cell walls and modified forms of LDL, LPS of Gram-negative bacteria (24). Compared to macrophages from wild-type animals, macrophages of SR-A-silenced mice exhibit 70–80% reduced uptake of acetylated LDL (25). Certain studies also have shown that inflammatory cytokines mediate the regulation of SR-A and foam cell formation on macrophages in atherosclerosis (26), as well as LPS induces SR-A expression in RAW264.7 cells (27). However, more and more studies suggest that SR-A is not the only receptor responsible for atherosclerosis.

It is well known that the high incidence of atherosclerosis is correlated with the high concentration of LDL and cholesterol in plasma. The activity of the LDL-R is another major determinant of plasma cholesterol levels. The cellular uptake and degradation of plasma is mediated by the LDL-R. It has been reported that the activity of LDL-R is normally under tight metabolic control via a feedback system, which is dependent on intracellular cholesterol concentration (2831). The system maintains a constant level of cholesterol in cells by controlling both the rate of cholesterol synthesis and the rate of cholesterol uptake from LDL. The feedback regulation is controlled through specific interactions of the sterol-regulatory element (SRE)-1 of the LDL-R promoter and a family of SRE-binding proteins (SREBPs), namely, SREBP-1 and SREBP-2 (3235). Moreover, a number of pro-inflammatory cytokines, such as interleukin-6, oncostatin M and TNF-α, have been shown to increase LDL-R gene expression under inflammatory stress (3638). We previously demonstrated in human vascular smooth muscle cells and mesangial cells that inflammatory cytokines disrupt LDL-R feedback regulation, allowing unregulated uptake of cholesterol in the cells causing foam cell formation (3942). However, the role of the LDL-R in cholesterol accumulation in macrophages remains to be elucidated.

In the present study, we investigated the effects of native LDL that consist mostly of cholesterol of plasma in circulation and macrophage-derived foam cells under inflammatory stress, and evaluated the roles of SR-A and LDL-R in this process. We demonstrated that LPS causes inflammatory stress and induces TNF-α secretion in a time-dependent manner consequently. LPS increased intracellular cholesterol accumulation in the RAW264.7 macrophage-like cell line (Fig. 1) and caused foam cell formation (Fig. 2). To explore the molecular mechanisms, we further determined the expression levels of LDL-R and SR-A mRNA and protein in RAW264.7 cells and found that, under physiological conditions, LDL-R was sensitive for downregulation of LDL loading. Intracellular TC and CE contents remained at a relatively constant level in the RAW264.7 cells. However, inflammation overrode this tight feedback and caused foam cell formation via increased expression of both SR-A and LDL-R (Figs. 35). The results of our study indicate that the synergy of dysregulation of LDL-R under inflammatory stress and upregulation of SR-A may contribute to macrophage-derived foam cell formation.

In conclusion, our findings indicate that a novel role for the synergy of upregulation of SR-A and dysregulation of LDL-R plays a significant role in macrophage foam cell formation under inflammatory stress.

Acknowledgements

The authors acknowledge the support of the National Natural Science Foundation of China (nos. 30530360 and 30772098).

References

1 

Libby P, Ridker PM and Hansson GK: Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 54:2129–2138. 2009. View Article : Google Scholar : PubMed/NCBI

2 

Galkina E and Ley K: Immune and inflammatory mechanisms of atherosclerosis. Annu Rev Immunol. 27:165–197. 2009. View Article : Google Scholar : PubMed/NCBI

3 

Krupinski J, Font A, Luque A, Turu M and Slevin M: Angiogenesis and inflammation in carotid atherosclerosis. Front Biosci. 13:6472–6482. 2008. View Article : Google Scholar : PubMed/NCBI

4 

Tahara N, Imaizumi T, Virmani R and Narula J: Clinical feasibility of molecular imaging of plaque inflammation in atherosclerosis. J Nucl Med. 50:331–334. 2009. View Article : Google Scholar : PubMed/NCBI

5 

Williams KJ and Tabas I: The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol. 15:551–561. 1995. View Article : Google Scholar : PubMed/NCBI

6 

Ylä-Herttuala S, Solakivi T, Hirvonen J, et al: Glycosaminoglycans and apolipoproteins B and A-I in human aortas: chemical and immunological analysis of lesion-free aortas from children and adults. Arteriosclerosis. 7:333–340. 1987.PubMed/NCBI

7 

Steinberg D, Parthasarathy S, Carew TE, et al: Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 320:915–924. 1989.PubMed/NCBI

8 

Li AC and Glass CK: The macrophage foam cell as a target for therapeutic intervention. Nat Med. 8:1235–1242. 2002. View Article : Google Scholar : PubMed/NCBI

9 

Pennant M, Davenport C, Bayliss S, Greenheld W, Marshall T and Hyde C: Community programs for the prevention of cardiovascular disease: a systematic review. Am J Epidemiol. 172:501–516. 2010. View Article : Google Scholar : PubMed/NCBI

10 

Bash LD, Erlinger TP, Coresh J, Marsh-Manzi J, Folsom AR and Astor BC: Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 53:596–605. 2009. View Article : Google Scholar : PubMed/NCBI

11 

Sherer Y, Zinger H and Shoenfeld Y: Atherosclerosis in systemic lupus erythematosus. Autoimmunity. 43:98–102. 2010. View Article : Google Scholar : PubMed/NCBI

12 

Doria A: Atherosclerosis and lupus: what we know and what we should know. J Rheumatol. 36:2380–2382. 2009. View Article : Google Scholar : PubMed/NCBI

13 

Ylä-Herttuala S, Rosenfeld ME, Parthasarathy S, et al: Gene expression in macrophage-rich human atherosclerotic lesions: 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. J Clin Invest. 87:1146–1152. 1991.

14 

Kunjathoor VV, Febbraio M, Podrez EA, et al: Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J Biol Chem. 277:49982–49988. 2002. View Article : Google Scholar

15 

Suzuki H, Kurihara Y, Takeya M, et al: A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature. 386:292–296. 1997. View Article : Google Scholar : PubMed/NCBI

16 

Shibata N and Glass CK: Regulation of macrophage function in inflammation and atherosclerosis. J Lipid Res. 50:S277–S281. 2009. View Article : Google Scholar : PubMed/NCBI

17 

Gallo LL, Atasoy R, Vahouny GV and Treadwell CR: Enzymatic assay for cholesterol ester hydrolase activity. J Lipid Res. 19:913–916. 1978.PubMed/NCBI

18 

Gamble W, Vaughan M, Kruth HS and Avigan J: Procedure for determination of free and total cholesterol in micro- or nanogram amounts suitable for studies with cultured cells. J Lipid Res. 19:1068–1070. 1978.PubMed/NCBI

19 

Saha P, Modarai B, Humphries J, Mattock K, Waltham M, Burnand KG and Smith A: The monocyte/macrophage as a therapeutic target in atherosclerosis. Curr Opin Pharmacol. 9:109–118. 2009. View Article : Google Scholar : PubMed/NCBI

20 

Jozefowski S, Arredouani M, Sulahian T and Kobzik L: Disparate regulation and function of the class A scavenger receptors SR-AI/II and MARCO. J Immunol. 175:8032–8041. 2005. View Article : Google Scholar : PubMed/NCBI

21 

Neyen C, Plüddemann A, Roversi P, Thomas B, Cai L, van der Westhuyzen DR, Sim RB and Gordon S: Macrophage scavenger receptor A mediates adhesion to apolipoproteins A-I and E. Biochemistry. 48:11858–11871. 2009. View Article : Google Scholar : PubMed/NCBI

22 

Greaves DR and Gordon S: The macrophage scavenger receptor at 30 years of age: current knowledge and future challenges. J Lipid Res. 50:S282–S286. 2009.PubMed/NCBI

23 

Osto E, Kouroedov A, Mocharla P, Akhmedov A, Besler C, Rohrer L, von Eckardstein A, Iliceto S, Volpe M, Lüscher TF and Cosentino F: Inhibition of protein kinase Cbeta prevents foam cell formation by reducing scavenger receptor A expression in human macrophages. Circulation. 118:2174–2182. 2008. View Article : Google Scholar : PubMed/NCBI

24 

Plüddemann A, Neyen C and Gordon S: Macrophage scavenger receptors and host-derived ligands. Methods. 43:207–217. 2007.

25 

Van Berkel TJ, Van Eck M, Herijgers N, Fluiter K and Nion S: Scavenger receptor classes A and B: their roles in atherogenesis and the metabolism of modified LDL and HDL. Ann NY Acad Sci. 902:113–126. 2000.PubMed/NCBI

26 

Li K, Yao W, Zheng X and Liao K: Berberine promotes the development of atherosclerosis and foam cell formation by inducing scavenger receptor A expression in macrophage. Cell Res. 19:1006–1017. 2009. View Article : Google Scholar : PubMed/NCBI

27 

Moore KJ and Freeman MW: Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler Thromb Vasc Biol. 26:1702–1711. 2006. View Article : Google Scholar : PubMed/NCBI

28 

Goldstein JL and Brown MS: The LDL receptor. Arterioscler Thromb Vasc Biol. 29:431–438. 2009. View Article : Google Scholar

29 

Mazière C and Mazière JC: Activation of transcription factors and gene expression by oxidized low-density lipoprotein. Free Radic Biol Med. 46:127–137. 2009.PubMed/NCBI

30 

Issandou M: Pharmacological regulation of low density lipoprotein receptor expression: current status and future developments. Pharmacol Ther. 111:424–433. 2006. View Article : Google Scholar : PubMed/NCBI

31 

Vainio S and Ikonen E: Macrophage cholesterol transport: a critical player in foam cell formation. Ann Med. 35:146–155. 2003. View Article : Google Scholar : PubMed/NCBI

32 

Sato R: Sterol metabolism and SREBP activation. Arch Biochem Biophys. 501:177–181. 2010. View Article : Google Scholar : PubMed/NCBI

33 

Osborne TF and Espenshade PJ: Evolutionary conservation and adaptation in the mechanism that regulates SREBP action: what a long, strange tRIP it’s been. Genes Dev. 23:2578–2591. 2009.PubMed/NCBI

34 

Bengoechea-Alonso MT and Ericsson J: SREBP in signal transduction: cholesterol metabolism and beyond. Curr Opin Cell Biol. 19:215–222. 2007. View Article : Google Scholar : PubMed/NCBI

35 

Shimano H: SREBPs: physiology and pathophysiology of the SREBP family. FEBS J. 276:616–621. 2009. View Article : Google Scholar : PubMed/NCBI

36 

Liu J, Zhang F, Li C, Lin M and Briggs MR: Synergistic activation of human LDL receptor expression by SCAP ligand and cytokine oncostatin M. Arterioscler Thromb Vasc Biol. 23:90–96. 2003. View Article : Google Scholar : PubMed/NCBI

37 

Gierens H, Nauck M, Roth M, Schinker R, Schürmann C, Scharnagl H, Neuhaus G, Wieland H and März W: Interleukin-6 stimulates LDL receptor gene expression via activation of sterol-responsive and Sp1 binding elements. Arterioscler Thromb Vasc Biol. 20:1777–1783. 2000. View Article : Google Scholar : PubMed/NCBI

38 

Hansson GK: Inflammatory mechanisms in atherosclerosis. J Thromb Haemost. 7(Suppl 1): 328–331. 2009. View Article : Google Scholar

39 

Ye Q, Chen Y, Lei H, Liu Q, Moorhead JF, Varghese Z and Ruan XZ: Inflammatory stress increases unmodified LDL uptake via LDL receptor: an alternative pathway for macrophage foam-cell formation. Inflamm Res. 58:809–818. 2009. View Article : Google Scholar : PubMed/NCBI

40 

Chen Y, Ruan XZ, Li Q, et al: Inflammatory cytokines disrupt LDL-receptor feedback regulation and cause statin resistance: a comparative study in human hepatic cells and mesangial cell. Am J Physiol Renal Physiol. 293:F680–F687. 2007. View Article : Google Scholar : PubMed/NCBI

41 

Ruan XZ, Moorhead JF, Fernando R, Wheeler DC, Powis SH and Varghese Z: Mechanisms of dysregulation of low-density lipoprotein receptor expression in vascular smooth muscle cells by inflammatory cytokines. Arterioscler Thromb Vasc Biol. 26:1150–1155. 2006. View Article : Google Scholar : PubMed/NCBI

42 

Ruan XZ, Varghese Z, Powis SH and Moorhead JF: Dysregulation of LDL receptor under the influence of inflammatory cytokines: a new pathway for foam cell formation. Kidney Int. 60:1716–1725. 2001. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

January 2013
Volume 7 Issue 1

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Su T, Zhao L, Ruan X, Zuo G and Gong J: Synergistic effect of scavenger receptor A and low-density lipoprotein receptor on macrophage foam cell formation under inflammatory stress. Mol Med Rep 7: 37-42, 2013
APA
Su, T., Zhao, L., Ruan, X., Zuo, G., & Gong, J. (2013). Synergistic effect of scavenger receptor A and low-density lipoprotein receptor on macrophage foam cell formation under inflammatory stress. Molecular Medicine Reports, 7, 37-42. https://doi.org/10.3892/mmr.2012.1170
MLA
Su, T., Zhao, L., Ruan, X., Zuo, G., Gong, J."Synergistic effect of scavenger receptor A and low-density lipoprotein receptor on macrophage foam cell formation under inflammatory stress". Molecular Medicine Reports 7.1 (2013): 37-42.
Chicago
Su, T., Zhao, L., Ruan, X., Zuo, G., Gong, J."Synergistic effect of scavenger receptor A and low-density lipoprotein receptor on macrophage foam cell formation under inflammatory stress". Molecular Medicine Reports 7, no. 1 (2013): 37-42. https://doi.org/10.3892/mmr.2012.1170